Enhancing rare disease trials: eCOA technology’s impact on sickle cell research
As the pharmaceutical industry continues to push the boundaries of innovation, the role of digital solutions like eCOA platforms will only grow in significance. For rare disease trials, where patient populations are small and logistical challenges are magnified, such tools offer a clear path toward more efficient, patient-centric research.